PP
Poplar Point Capital Partners Lp
Other
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Poplar Point Capital Partners Lp. Officer active across 2 companies, notably Gyrodyne, LLC. Cumulatively, 8 filings have been published. Split: 7 buys · 1 sell. Total volume traded: €394k. Activity tracked since 27 August 2021. The latest transaction was disclosed on 18 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Poplar Point Capital Partners Lp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
14,000 股@ US$0.6313.2% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007144:0
2,597 股@ US$0.6352.6% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007136:0
31,703 股@ US$0.6934.1% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007133:0
917 股@ US$0.580.8% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007148:0
13,292 股@ US$0.60912.3% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007146:0
25,033 股@ US$0.619924.2% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007139:0
14,645 股@ US$0.5812.8% 占其流量Common Stock, par value $0.01 per shareSEC:0001398344-25-007141:0
30,000 股@ US$13.04100.0% 占其流量Common StockSEC:0001104659-21-111223:0
About Poplar Point Capital Partners Lp
POPLAR POINT CAPITAL PARTNERS LP is a declarant with 8 filings in total. In the recent filings available, they cover the period from 2021-08-30 to 2025-04-15, with buys of EUR 61231 and sells of EUR 332755. The companies mentioned are NovaBay Pharmaceuticals, Inc. and Gyrodyne, LLC.